Dose- and time-dependent neuroprotective effects of Pycnogenol® following traumatic brain injury

Journal of Neurotrauma

Volumn 30, Issue 17, 2013, Pages 1542-1549

  Ansari, Mubeen A ^a   Roberts, Kelly N ^a   Scheff, Stephen W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bioflavonoids; Natural compounds; Neurotrauma; Oxidative stress; Pycnogenol; Synaptic proteins; Traumatic brain injury

Indexed keywords

CELL PROTEIN; DREBRIN; POSTSYNAPTIC DENSITY PROTEIN 95; PYCNOGENOL; SYNAPSE ASSOCIATED PROTEIN 97; SYNAPSIN I; SYNAPTOPHYSIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG EFFICACY; HIPPOCAMPUS; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; POST HOC ANALYSIS; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; MALE; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PINUS; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS;

EID: 84882692938     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2013.2910     Document Type: Article

References (62)

1. Faul M, Xu L, Wald M, and Coronado V. (2010). Traumatic brain injury in the United States: Emergency department visits, hospitalizations and deaths 2002-2006. Atlanta, GA: Centers for Disease control and Prevention National Center for Injury Prevention and Control
2. Baldwin SA, Gibson T, Callihan CT, Sullivan PG, Palmer E, and Scheff SW. (1997). Neuronal cell loss in the CA3 subfield of the hippocampus following cortical contusion utilizing the optical disector method for cell counting. J Neurotrauma 14:385-398
3. Hall ED, Vaishnav RA, and Mustafa AG. (2010). Antioxidant therapies for traumatic brain injury. Neurotherapeutics 7:51-61
4. Hovda DA, Yoshino A, Kawamata T, Katayama Y, and Becker DP. (1991). Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: A cytochrome oxidase histochemistry study. Brain Res 567:1-10
5. Kawamata T, Katayama Y, Hovda DA, Yoshino A, and Becker DP. (1995). Lactate accumulation following concussive brain injury: The role of ionic fluxes induced by excitatory amino acids. Brain Res 674:196-204
6. Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, and McIntosh TK. (2001). The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 24:169-181
7. McIntosh TK, Smith DH, Meaney DF, Kotapka MJ, Gennarelli TA, and Graham DI. (1996). Neuropathological sequelae of traumatic brain injury: Relationship to neurochemical and biomechanical mechanisms. Lab Invest 74:315-342
8. Scheff SW, Price DA, Hicks RR, Baldwin SA, Robinson S, and Brackney C. (2005). Synaptogenesis in the hippocampal CA1 field following traumatic brain injury. J Neurotrauma 22:719-732
9. Xiong Y, Gu Q, Peterson PL, Muizelaar JP, and Lee CP. (1997). Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J Neurotrauma 14:23-34
10. Margulies S, and Hicks R. (2009). Combination therapies for traumatic brain injury: Prospective considerations. J Neurotrauma 26:925-939
11. Biegon A, Fry PA, Paden CM, Alexandrovich A, Tsenter J, and Shohami E. (2004). Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: Implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci USA 101:5117-5122
12. Shao C, Roberts KN, Markesbery WR, Scheff SW, and Lovell MA. (2006). Oxidative stress in head trauma in aging. Free Radic Biol Med 41:77-85
13. Singh IN, Sullivan PG, and Hall ED. (2007). Peroxynitrite-mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers. J Neurosci Res 85:2216-2223
14. Bayir H, Kagan VE, Clark RS, Janesko-Feldman K, Rafikov R, Huang Z, Zhang X, Vagni V, Billiar TR, and Kochanek PM. (2007). Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Neurochem 101:168-181
15. Hall ED, Detloff MR, Johnson K, and Kupina NC. (2004). Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma 21:9-20
16. Cayabyab FS, Khanna R, Jones OT, and Schlichter LC. (2000). Suppression of the rat microglia Kv1.3 current by src-family tyrosine kinases and oxygen/glucose deprivation. Eur J Neurosci 12:1949-1960
17. de la Monte SM, Neely TR, Cannon J, and Wands Jr. (2000). Oxidative stress and hypoxia-like injury cause Alzheimer-type molecular abnormalities in central nervous system neurons. Cell Mol Life Sci 57:1471-1481
18. Matzilevich DA, Rall JM, Moore AN, Grill RJ, and Dash PK. (2002). High-density microarray analysis of hippocampal gene expression following experimental brain injury. J Neurosci Res 67:646-663
19. Gilmer LK, Ansari MA, Roberts KN, and Scheff SW. (2010). Agerelated mitochondrial changes after traumatic brain injury. J Neurotrauma 27:939-950
20. Kotulska K, LePecheur M, Marcol W, Lewin-Kowalik J, Larysz-Brysz M, Paly E, Matuszek I, and London J. (2006). Overexpression of copper/zinc-superoxide dismutase in transgenic mice markedly impairs regeneration and increases development of neuropathic pain after sciatic nerve injury. J Neurosci Res 84:1091-1097
21. Wu A, Ying Z, and Gomez-Pinilla F. (2006). Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Exp Neurol 197:309-317
22. Ansari MA, Roberts KN, and Scheff SW. (2008). A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI. J Neurotrauma 25:513-526
23. Ansari MA, Roberts KN, and Scheff SW. (2008). Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic Biol Med 45:443-452
24. Scheff SW, Ansari MA, and Roberts KN. (2013). Neuroprotective effect of Pycnogenol(R) following traumatic brain injury. Exp Neurol 239:183-191
25. Yen TL, Hsu CK, Lu WJ, Hsieh CY, Hsiao G, Chou DS, Wu GJ, and Sheu Jr. (2012). Neuroprotective effects of xanthohumol, a prenylated flavonoid from hops (Humulus lupulus), in ischemic stroke of rats. J Agricull Food Chem 60:1937-1944
26. Mercer LD, Kelly BL, Horne MK, and Beart PM. (2005). Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: Investigations in primary rat mesencephalic cultures. Biochem Pharmacol 69:339-345
27. Ansari MA, Keller JN, and Scheff SW. (2008). Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity. Free Radic Biol Med 45:1510-1519
28. Singh IN, Sullivan PG, Deng Y, Mbye LH, and Hall ED. (2006). Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: Implications for neuroprotective therapy. J Cereb Blood Flow Metab 26:1407-1418
29. Tunon MJ, Garcia-Mediavilla MV, Sanchez-Campos S, and Gonzalez-Gallego J. (2009). Potential of flavonoids as anti-inflammatory agents: Modulation of pro-inflammatory gene expression and signal transduction pathways. Curr Drug Metab 10:256-271
30. Ince I, Yesil-Celiktas O, Karabay-Yavasoglu NU, and Elgin G. (2009). Effects of Pinus brutia bark extract and Pycnogenol in a rat model of carrageenan induced inflammation. Phytomedicine 16:1101-1104
31. Ryan J, Croft K, Mori T, Wesnes K, Spong J, Downey L, Kure C, Lloyd J, and Stough C. (2008). An examination of the effects of the antioxidant Pycnogenol on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. J Psychopharmacol 22:553-562
32. Rohdewald P. (2002). A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Intl J Clin Pharmacol Therapeut 40:158-168
33. Baldwin SA, Fugaccia I, Brown DR, Brown LV, and Scheff SW. (1996). Blood-brain barrier breach following cortical contusion in the rat. J Neurosurg 85:476-481
34. Bistrian BR, Askew W, Erdman JW, and Oria MP. (2011). Nutrition and traumatic brain injury: A perspective from the Institute of Medicine Report. J Parent Enter Nutrit 35:556-559
35. Itoh T, Imano M, Nishida S, Tsubaki M, Hashimoto S, Ito A, and Satou T. (2011). (-)-Epigallocatechin-3-gallate protects against neuronal cell death and improves cerebral function after traumatic brain injury in rats. Neuromol Med 13:300-309
36. Schultke E, Kamencic H, Zhao M, Tian GF, Baker AJ, Griebel RW, and Juurlink BH (2005). Neuroprotection following fluid percussion brain trauma: A pilot study using quercetin. J Neurotrauma 22:1475-1484
37. Sharma S, Zhuang Y, Ying Z, Wu A, and Gomez-Pinilla F. (2009). Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma. Neuroscience 161:1037-1044
38. Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, Kocak A, and Yologlu S. (2007). Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 294:137-144
39. Chen CC, Hung TH, Wang YH, Lin CW, Wang PY, Lee CY, and Chen SF. (2012). Wogonin improves histological and functional outcomes, and reduces activation of TLR4/NF-kappaB signaling after experimental traumatic brain injury. PLoS One 7:e30294
40. Chen SF, Hsu CW, Huang WH, and Wang JY. (2008). Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury. Br J Pharmacol 155:1279-1296
41. Laird MD, Sukumari-Ramesh S, Swift AE, Meiler SE, Vender JR, and Dhandapani KM. (2010). Curcumin attenuates cerebral edema following traumatic brain injury in mice: A possible role for aquaporin-4? J Neurochem 113:637-648
42. Lee HF, Lee TS, and Kou YR. (2012). Anti-inflammatory and neuroprotective effects of triptolide on traumatic brain injury in rats. Respir Physiol Neurobiol 182:1-8
43. Morales DM, Marklund N, Lebold D, Thompson HJ, Pitkanen A, Maxwell WL, Longhi L, Laurer H, Maegele M, Neugebauer E, Graham DI, Stocchetti N, and McIntosh TK
44. Di Giovanni S, Movsesyan V, Ahmed F, Cernak I, Schinelli S, Stoica B, and Faden AI. (2005). Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci USA 102:8333-8338
45. Singleton RH, Yan HQ, Fellows-Mayle W, and Dixon CE. (2010). Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma 27:1091-1099
46. Cho KJ, Yun CH, Packer L, and Chung AS. (2001). Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines. Ann NY Acad Sci 928:141-156
47. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, and Payrastre B. (1999). Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol32:279-286
48. Schroeter H, Spencer JP, Rice-Evans C, and Williams RJ. (2001). Flavonoids protect neurons from oxidized low-density-lipoproteininduced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358:547-557
49. Spencer JP. (2007). The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2:257-273
50. Williams RJ, Spencer JP, and Rice-Evans C (2004). Flavonoids: Antioxidants or signalling molecules? Free Radic Biol Med 36:838-849
51. Carloni S, Girelli S, Scopa C, Buonocore G, Longini M, and Balduini W. (2010). Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia. Autophagy 6:366-377
52. Endo H, Nito C, Kamada H, Nishi T, and Chan PH. (2006). Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocampal neurons after transient global cerebral ischemia in rats. J Cereb Blood Flow Metab 26:1479-1489
53. Hu LY, Sun ZG, Wen YM, Cheng GZ, Wang SL, Zhao HB, and Zhang XR. (2010). ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats. Neuroscience 169:1046-1062
54. Noshita N, Lewen A, Sugawara T, and Chan PH. (2002). Akt phosphorylation and neuronal survival after traumatic brain injury in mice. Neurobiol Dis 9:294-304
55. Shapira M, Licht A, Milman A, Pick CG, Shohami E, and Eldar-Finkelman H. (2007). Role of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injury. Mol Cell Neurosci 34:571-577
56. Shein NA, Tsenter J, Alexandrovich AG, Horowitz M, and Shohami E. (2007). Akt phosphorylation is required for heat acclimation-induced neuroprotection. J Neurochem 103:1523-1529
57. Seger R, and Krebs EG. (1995). The MAPK signaling cascade. FASEB J 9:726-735
58. Azevedo MF, Camsari C, Sa CM, Lima CF, Fernandes-Ferreira M, and Pereira-Wilson C. (2010). Ursolic acid and luteolin-7-glucoside improve lipid profiles and increase liver glycogen content through glycogen synthase kinase-3. Phytother Res 24:S220-224
59. de la Torre AV, Junyent F, Folch J, Pelegri C, Vilaplana J, Auladell C, Beas-Zarate C, Pallas M, Verdaguer E, and Camins A. (2012). GSK3beta inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neurons. Pharmacol Res 65:66-73
60. Johnson JL, Rupasinghe SG, Stefani F, Schuler MA, and Gonzalez de Mejia E. (2011). Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3beta enzymatic activity by lowering the interaction energy within the binding cavity. J Med Food 14:325-333
61. Parajuli P, Joshee N, Chinni SR, Rimando AM, Mittal S, Sethi S, and Yadav AK. (2011). Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-kappaB signaling. J Neurooncol 101:15-24
62. Vauzour D, Vafeiadou K, Rice-Evans C, Williams RJ, and Spencer JP. (2007). Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 103:1355-1367